Current role
Biotechnology · Healthcare
Board Member
2026-06-05–present
Martine Zimmermann, Pharm.D.
Board Member
Ligand Pharmaceuticals Inc (LGND)Equibles does not estimate personal net worth.
Get an email with a short summary when Ligand Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get LGND alertsAbout Martine Zimmermann, Pharm.D.
Martine Zimmermann, Pharm.D. is recorded as Board Member at Ligand Pharmaceuticals Inc (LGND) since June 5, 2026. Ligand Pharmaceuticals Inc reported in an 8-K filed June 9, 2026 that Martine Zimmermann, Pharm.D. was appointed director of the Company, effective June 5, 2026. Ligand Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ligand Pharmaceuticals Inc includes Todd C. Davis (CEO and Board Member), Tavo Espinoza (CFO), Jason Haas (Board Member) and 7 others.
“Martine Zimmermann, Pharm.D. | 17,319,859 | 213,900 | 1,257,231”
Affiliation history
-
Current
2026-06-05–present
Company network
Leadership on record at Ligand Pharmaceuticals Inc
- Todd C. Davis CEO, Board Member
- Tavo Espinoza CFO
- Jason Haas Board Member
- Jason M. Aryeh Board Member
- Jennifer Cochran, Ph.D. Board Member
- John L. LaMattina Board Member
- John L. LaMattina, Ph.D. Board Member
- John W. Kozarich Board Member
- John W. Kozarich, Ph.D. Board Member
- Martine Zimmermann Board Member